- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 109.45M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 111.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 117.26M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $36.34M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Capex | Q1 2026 · Mar 31, 2026 | $14.14M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $17.09M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $16.94M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $10.26M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $392.76M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $392.58M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $162.55M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $197.19M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $575.19M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $603.44M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $698.68M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $700.46M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $127.92M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $120.82M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $671.43M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $657.54M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $304.29M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $319.36M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.25B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.26B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.04 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $19.13M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $16.5M |
| Net Income | Q1 2026 · Mar 31, 2026 | $4.31M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.6M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $12.54M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$981K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $36.41M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $19.1M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $178.54M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $124.01M |
| Revenue | Q1 2026 · Mar 31, 2026 | $214.95M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $143.11M |